Introduction There are limited data on the influence of different anti-cancer therapies on
lymphocyte subpopulations and their relationships to survival of non-small cell lung cancer …

Purpose To cross-validate and expand a predictive atlas that can estimate geometric
patterns of lung tumor shrinkage during radiation therapy using data from 2 independent …

Lung cancer is one of the most common malignancies worldwide; however, its detailed
molecular mechanism remains largely unknown. Long non‑coding RNAs (lncRNAs) have …

Background BRAF mutations occur in 1% to 4% of non–small-cell lung cancer (NSCLC)
cases. Previous retrospective studies have reported similar outcomes for BRAF-mutated …

ABSTRACT EGF receptors (EGFRs) are often overexpressed or constitutively activated in
non-small-cell lung cancer, and are an important therapeutic target. EGFR signaling can be …

Survival and prognostic factors after moderately hypofractionated palliative thoracic
radiotherapy for Page 1 Consent of the head of the institute (Prof. Dr. med. Michael Flentje) …

Brucea javanica oil (BJO) is a traditional herbal medicine in China for the effective treatment
of various diseases due to multifaceted activities. As the most common formulation, BJO …

To observe drug-induced hepatotoxicity by long-term gefitinib administration in the treatment
of non-small-cell lung cancer. The data of 101 patients with locally advanced or metastatic …

The aim of this study was to investigate the mechanism by which KLF6-SV1 promoted lung
cancer metastasis through tumor-associated macrophages (TAMs). Plasmid transfection …

Background: Transforming growth factor β-induced protein (TGFBI) is a secreted protein that
mediates cell anchoring to the extracellular matrix. This protein is downregulated in lung …